Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

CAPS Rating: 2 out of 5

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.

Recs

0
Player Avatar CarlosDK (< 20) Submitted: 1/10/2013 8:12:04 AM : Underperform Start Price: $100.68 ALXN Score: -26.32

expensive on all valuations

Featured Broker Partners


Advertisement